Hemolytic anemia risk factors: Difference between revisions
Jump to navigation
Jump to search
Shyam Patel (talk | contribs) |
Shyam Patel (talk | contribs) |
||
| Line 8: | Line 8: | ||
==Risk Factors== | ==Risk Factors== | ||
Oxidative stress in the setting of G6PD deficiency:<ref name="pmid24372186">{{cite journal| author=Luzzatto L, Seneca E| title=G6PD deficiency: a classic example of pharmacogenetics with on-going clinical implications. | journal=Br J Haematol | year= 2014 | volume= 164 | issue= 4 | pages= 469-80 | pmid=24372186 | doi=10.1111/bjh.12665 | pmc=4153881 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24372186 }} </ref> | '''Oxidative stress in the setting of G6PD deficiency''':<ref name="pmid24372186">{{cite journal| author=Luzzatto L, Seneca E| title=G6PD deficiency: a classic example of pharmacogenetics with on-going clinical implications. | journal=Br J Haematol | year= 2014 | volume= 164 | issue= 4 | pages= 469-80 | pmid=24372186 | doi=10.1111/bjh.12665 | pmc=4153881 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24372186 }} </ref> | ||
*Use of primiquine for malaria treatment | *Use of primiquine for malaria treatment | ||
*Use of dapsone for PCP or leprosy treatment | *Use of dapsone for PCP or leprosy treatment | ||
| Line 16: | Line 16: | ||
*Use of nitrofurantoin for treatment of a urinary tract infection | *Use of nitrofurantoin for treatment of a urinary tract infection | ||
Cardiovascular surgery-related risk factors: | '''Cardiovascular surgery-related risk factors''': | ||
*Presence of a mechanical mitral or aortic valve | *Presence of a mechanical mitral or aortic valve | ||
*High shear stress from ECMO circuit | *High shear stress from ECMO circuit | ||
Genetic conditions: | '''Genetic conditions''': | ||
*Hereditary spherocytosis | *Hereditary spherocytosis | ||
*Hereditary elliptocytosis | *Hereditary elliptocytosis | ||
Revision as of 06:57, 5 October 2017
|
Hemolytic anemia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hemolytic anemia risk factors On the Web |
|
American Roentgen Ray Society Images of Hemolytic anemia risk factors |
|
Risk calculators and risk factors for Hemolytic anemia risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Risk Factors
Oxidative stress in the setting of G6PD deficiency:[1]
- Use of primiquine for malaria treatment
- Use of dapsone for PCP or leprosy treatment
- Consumption of fava beans as part of a Mediterranean diet
- Use of sulfa drugs like trimethoprim-sulfamethoxazole for treatment of skin, urinary tract, or other infections
- Use of phenazopyridine for alleviating symptoms of dysuria
- Use of nitrofurantoin for treatment of a urinary tract infection
Cardiovascular surgery-related risk factors:
- Presence of a mechanical mitral or aortic valve
- High shear stress from ECMO circuit
Genetic conditions:
- Hereditary spherocytosis
- Hereditary elliptocytosis
References
- ↑ Luzzatto L, Seneca E (2014). "G6PD deficiency: a classic example of pharmacogenetics with on-going clinical implications". Br J Haematol. 164 (4): 469–80. doi:10.1111/bjh.12665. PMC 4153881. PMID 24372186.